Literature DB >> 19543839

P53 Arg72Pro polymorphism in gastric cancer patients.

Lessileia Gomes de Souza1, Jacqueline Miranda de Lima, Ismael Dale Cotrim Guerreiro da Silva, Nora Manoukian Forones.   

Abstract

INTRODUCTION: Polymorphism in codon 72, exon 4 of p53 may alter apoptosis and cancer progression. PATIENTS AND METHODS: P53 Arg72Pro genotype was assessed by PCR from 84 gastric cancer patients and 185 controls. The control group was comparable in sex, race, age, smoking, and alcohol intake to the cancer group. RESULTS AND DISCUSSION: There was no difference among the frequency of the alleles or genotypes between the groups. P53 Pro/Pro was associated to a lower risk of metastatic disease (p = 0.02) but not to lymph nodes metastasis or worst prognosis. Arg/Arg or Arg/Pro genotype may be associated to metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543839     DOI: 10.1007/s12029-009-9078-7

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  20 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 3.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  Flexibility: the key to p53 function?

Authors:  J Milner
Journal:  Trends Biochem Sci       Date:  1995-02       Impact factor: 13.807

5.  Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.

Authors:  Guillermo Ignacio Pérez-Pérez; Francisco Javier Bosques-Padilla; Maria Luisa Crosatti; Rolando Tijerina-Menchaca; Elvira Garza-González
Journal:  Scand J Gastroenterol       Date:  2005-01       Impact factor: 2.423

6.  [Association of the p53 codon 72 polymorphism to gastric cancer risk in a hight risk population of Costa Rica].

Authors:  Warner Alpízar-Alpízar; Rafaela Sierra; Patricia Cuenca; Clas Une; Fernando Mena; Guillenno Ignacio Pérez-Pérez
Journal:  Rev Biol Trop       Date:  2005 Sep-Dec       Impact factor: 0.723

7.  A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.

Authors:  Sun Young Yi; Woon Jung Lee
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

8.  Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.

Authors:  Ming Yang; Yongli Guo; Xuemei Zhang; Xiaoping Miao; Wen Tan; Tong Sun; Dan Zhao; Dianke Yu; Junniao Liu; Dongxin Lin
Journal:  Carcinogenesis       Date:  2007-07-17       Impact factor: 4.944

9.  Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.

Authors:  Zun-Wu Zhang; Paul Newcomb; Andrew Hollowood; Roger Feakins; Moganaden Moorghen; Alan Storey; Michael J G Farthing; Derek Alderson; Jeff Holly
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

Review 10.  P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature.

Authors:  Yong Zhou; Ni Li; Wen Zhuang; Guan-Jian Liu; Tai-Xiang Wu; Xun Yao; Liang Du; Mao-Ling Wei; Xiao-Ting Wu
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

View more
  4 in total

1.  An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.

Authors:  Kui-Jie Liu; Hai-Zhi Qi; Hong-Liang Yao; San-Lin Lei; Zhen-Dong Lei; Tie-Gang Li; Hua Zhao
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

Review 2.  Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries.

Authors:  Miguel Angel Chiurillo
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.

Authors:  Roghayeh Dehghan; Mohammad Ali Hosseinpour Feizi; Nasser Pouladi; Esmaeil Babaei; Vahid Montazeri; Ashraf Fakhrjoo; Ayda Sedaei; Parvin Azarfam; Masoumeh Nemati
Journal:  Pathol Oncol Res       Date:  2014-11-20       Impact factor: 3.201

4.  Risk factors for gastric cancer in Latin America: a meta-analysis.

Authors:  Patricia Bonequi; Fernando Meneses-González; Pelayo Correa; Charles S Rabkin; M Constanza Camargo
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.